Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.17304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Mathieu Victor Paulin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Prednisolone, Arginine Vasopressin, Glycopeptides, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Saskatchewan WCVM Companion Animal Health Fund.
Abstract (Originalsprache)
Background
The pathophysiology of polyuria and polydipsia secondary to exogenous glucocorticoid excess is incompletely understood.
Objective
Investigate plasma AVP (pAVP) and serum CoP (sCoP) concentrations in healthy dogs before, during, and after abrupt discontinuation of a long-term course of orally administered prednisolone. Animals Eight healthy neutered young adult research Beagles.
Methods
In our prospective longitudinal study, Beagles were treated with a placebo PO q24h for 15 days (baseline), followed by a 35-day course of prednisolone (2.35-2.75 mg/kg PO q24h) and then abrupt discontinuation of prednisolone. Serial pAVP and sCoP concentrations, urine specific gravity (USG) and calculated plasma osmolality (pOsmcalculated) were determined during placebo and prednisolone administration, and up to 4 weeks after prednisolone discontinuation. Paired plasma samples for pAVP measurement were obtained in EDTA tubes with (pAVPP800) and without (pAVPEDTA) a proprietary combination of protease, esterase, and dipeptidyl peptidase-IV inhibitors (BD Biosciences P800).
Results
Mean pAVPP800 and sCoP concentrations were significantly lower at the end of the prednisolone course (25.8 ± 8.1 pg/mL and 166 pg/mL, range, 131-223) vs baseline (34.1 ± 5.4 pg/mL and 243 pg/mL, range, 157-336; P = .02, P = .02, respectively). Correlations between pAVPP800 and sCoP (r = .77, P = .001) and pAVPP800 and USG (r = .61, P = .02) were positive, despite no correlation between pAVPP800 and pOsmcalculated, sCoP and pOsmcalculated, and sCoP and USG. On paired samples, mean pAVPEDTA was significantly lower (5.0 ± 2.5 pg/mL) than mean pAVPP800 (34.1 ± 5.4 pg/mL; P < .0001). Conclusions and Clinical Importance Orally administered prednisolone led to markedly decreased plasma AVP and serum CoP concentrations despite increased calculated plasma osmolality and stable systolic blood pressure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
- Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
ORCID-Profile: Mathieu Victor Paulin
Förderung
- University of Saskatchewan WCVM Companion Animal Health Fund
Zitieren
APA
Paulin, M. V., Mehrabanpour, D., Unniappan, S., & Snead, E. C. R. (2025). Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17304
Vancouver
Paulin MV, Mehrabanpour D, Unniappan S, Snead ECR. Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.17304
BibTeX
@article{Paulin2025,
author = {Paulin, Mathieu Victor and Mehrabanpour, Dorsa and Unniappan, Suraj and Snead, Elisabeth C R},
title = {Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.17304}
}
EUVIMED